The majority of prostate cancer patients are diagnosed with multiple primary malignant foci. The distinct foci are exceptionally heterogeneous with regard to DNA mutations, but whether this is ...
Tuft cells are chemosensory epithelial cells that increase in number following infection or injury to robustly activate the innate immune response to alleviate or promote disease. Recent studies of ...
Prognostic value of metastasis pattern for morbidity in prostate cancer measured by quantitative bone scintigraphy. Background: Prostate cells released into expressed prostatic secretions (EPS) during ...
Salvage prostatectomy for prostate cancer (CaP): Data from the Surveillance Epidemiology and End Results (SEER) database No significant financial relationships to disclose. This is an ASCO Meeting ...
It may be possible to restore drug-resistant neuroendocrine prostate cancer to a state that responds to treatment by depletion of a certain protein in cancer cells. A recent study published in ...
It may be possible to restore drug-resistant neuroendocrine prostate cancer to a state that responds to treatment by depletion of a certain protein in cancer cells. A recent study by the University of ...
Picking the right target and helping recruit a wider range of anti-tumor immune cells can help improve CAR T-cell therapy against advanced prostate cancer, according to new preclinical work from Fred ...
Medical Laboratory Scientist at bench with micropipettes. — Courtesy U.S. National Institutes of Health (Public Domain) Medical Laboratory Scientist at bench with micropipettes. — Courtesy U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results